Camp4 Therapeutics (CAMP) Other financing activities (2024 - 2025)

Camp4 Therapeutics' (CAMP) quarterly Other financing activities came in at -$14.9 million in Q4 2025, down 1720.73% year-on-year from $921188.9 in Q4 2024, and down 200.0% quarter-over-quarter from $14.9 million in Q3 2025.

Camp4 Therapeutics (CAMP) Other financing activities (2024 - 2025) Analysis & Trends

Camp4 Therapeutics has disclosed Other financing activities across 2 years of filings, most recently posting -$14.9 million for Q4 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Alterity Therapeutics 814,307.08 Bn 814,307.05 Bn -
2 Belite Bio 55,320.00 Bn 55,320.00 Bn -
3 Quantum Biopharma 17,149.72 Bn 17,149.72 Bn -
4 Legend Biotech 3,590.00 Bn 3,589.71 Bn 242.10 Mn
5 Akari Therapeutics 1,650.72 Bn 1,650.72 Bn -
6 Evaxion A 1,522.09 Bn 1,522.07 Bn -
7 Psyence Biomedical 229.39 Bn 229.38 Bn -
8 Vertex Pharmaceuticals 113.09 Bn 105.85 Bn 2.59 Bn
9 Abivax 90.15 Bn 90.15 Bn -
10 Camp4 Therapeutics 245.02 Mn 245.02 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2025 -14.93 Mn
Dec 31, 2025 -14.93 Mn
Sep 30, 2025 14.93 Mn
Sep 30, 2025 14.93 Mn
Dec 31, 2024 -820,000.00
Dec 31, 2024 -820,000.00
Sep 30, 2024 212,000.00
Sep 30, 2024 212,000.00